Physician

Arina Monica Gliga, MD

According to 2025 Medicare claims, Arina Gliga, MD (NPI: 1811097207) practices endocrinology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is SOUTHWEST GENERAL MEDICAL GROUP INC (NPI: 1134239676; TIN: 341652755) and primary practice location at 44130-3300.

Gliga's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 220 traditional Medicare patients, billed 586 HCPCS/CPT codes, and received $32,960 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,478 prescription claims across 387 beneficiaries totaling $395,469 in drug costs, led by Rybelsus (Semaglutide). DME data shows 103 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $63,796 to $32,960. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,511 and ending at $6,614.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	388	1,413	$63,796
2016	350	1,226	$53,593
2017	313	1,207	$51,031
2018	266	886	$41,098
2019	247	715	$24,989
2020	230	758	$23,632
2021	226	674	$35,488
2022	229	668	$39,128
2023	212	624	$37,149
2024	220	586	$32,960

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	343	2,534	$663,865
2016	319	2,395	$685,933
2017	324	2,316	$720,454
2018	297	2,230	$712,035
2019	301	2,044	$663,734
2020	305	2,092	$615,149
2021	298	2,038	$726,414
2022	308	2,123	$589,687
2023	345	2,232	$700,580
2024	387	2,478	$395,469

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	206	537	$9,486
2016	201	484	$8,191
2017	157	385	$5,007
2018	120	348	$4,357
2019	93	281	$3,596
2020	73	201	$4,155
2021	64	186	$4,821
2022	47	141	$1,793
2023	48	135	$5,336
2024	39	103	$6,309

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	15	20	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	38	64	$83
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	37	37	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	181	386	$57
83036	Hemoglobin a1c level	35	48	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rybelsus	Semaglutide	25	1,980	$59,480
Januvia	Sitagliptin Phosphate	32	2,020	$37,133
Farxiga	Dapagliflozin Propanediol	29	1,710	$31,777
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	39	3,006	$31,245
Tresiba Flextouch U-200	Insulin Degludec	22	1,208	$27,624

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	19	$4,862
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	27	66	$1,413
A4259	Lancets, per box of 100	N	12	18	$34

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arina Monica Gliga, MD?

Tedicare shows public-source Medicare data for Arina Monica Gliga, MD (NPI 1811097207), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arina Monica Gliga, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arina Monica Gliga, MD?

Arina Monica Gliga, MD is linked to SOUTHWEST GENERAL MEDICAL GROUP INC (billing NPI 1134239676) in the available physician profile data.

Does Arina Monica Gliga, MD have Open Payments data?

Arina Monica Gliga, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.